DZ Bank Aktienanleihe MRK 28.03.2.../ DE000DJ6QK44 /
2024-05-30 2:34:39 PM | Chg.+0.100 | Bid3:23:18 PM | Ask3:23:18 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
100.570EUR | +0.10% | 100.580 Bid Size: 200,000 |
100.680 Ask Size: 200,000 |
MERCK KGAA O.N. | 120.00 EUR | 2025-03-28 | Call |
GlobeNewswire
1:00 PM
LAVA Therapeutics to Participate in the Jefferies Global Healthcare Conference
GlobeNewswire
05-29
Jeito Capital announces the acquisition by Merck & Co (NYSE: MRK) of its portfolio company EyeBio fo...
GlobeNewswire
05-07
CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...
GlobeNewswire
05-06
Press Release Biocartis NV: Biocartis and Merck to Collaborate on Improving Patient Access to Person...
GlobeNewswire
03-04
C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Ger...
GlobeNewswire
2023-12-21
Arch Biopartners Receives Approval from Ethics Committee in Turkey to Proceed with Phase II Cardiac ...
GlobeNewswire
2023-12-14
ITM Executes License Agreement to Obtain Worldwide Exclusive License for the Clinical Development an...
GlobeNewswire
2023-10-17
ImmunOs Therapeutics Announces Clinical Trial Collaboration with Merck & Co., Inc., Rahway, NJ, USA